FedEx takes precautionary steps to manage CO2 outgassing in their newest B-777 aircraft
This is a problem that confronts air carriers of temperature-sensitive products, more than the manufacturers themselves, but pharma shippers will have to factor it into their logistics plans in certain circumstances nonetheless. Dry ice—frozen CO2—has been a traditional source of cold to keep temperature-sensitive products at specified temperature (usually, 2-8°C). According to Richard Smith, managing director of the Healthcare Solutions business unit at FedEx (Memphis), the latest generation of Boeing 700-series aircraft (with which FedEx is updating its air-cargo fleet) achieves its higher energy efficiencies, in part, through tight controls on the cabin environment. As a result, if a large shipment of temperature-sensitive pharmaceuticals are being conveyed, and those pharmaceuticals are cooled by dry ice packages, the cabin environment can be affected. There are numerous technical solutions: using phase-change materials or liquid nitrogen for refrigeration, or deploying battery-powered containers with battery-powered refrigeration units; or even limiting the quantity of CO2-containing packages in the shipment. But the upshot is that the quantity of CO2 onboard, and the rate at which it evaporates, needs to be factored into a flight.
Smith, speaking at the Opal Events Pharmaceutical Supply Chain Summit (Baltimore, June 6), also detailed a service that the company is now offering for shipment of controlled room-temperature (CRT) drugs (usually, 15-30°C). Numerous shippers are now deploying engineered thermal blankets around pallets of drug, to protect the shipment from extreme high or low temperatures. Many times, the blanket is considered a disposable item at the end of the shipment. But, by offering blankets FedEx has purchased essentially as a rental service to shippers, and recycling the blankets for new shipments, FedEx can lower the overall shipping expense. FedEx uses blankets from Amsafe, Inc. (Phoenix); Smith says that they have proved especially popular for shipment runs from India to the US.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.